Journal article
Ovarian Function Suppression in Premenopausal Women With Concurrent Endocrine Therapy Use
Clinical breast cancer, Vol.23(4), pp.454-460
06/2023
DOI: 10.1016/j.clbc.2023.03.009
PMID: 37076363
Abstract
Almost 20% of patients receiving ovarian function suppression (OFS) and endocrine therapy (ET) for breast cancer treatment had inadequate OFS within the first year of treatment. Few studies have explored the long-term effectiveness of OFS to maintain estrogen suppression.
This retrospective, single institution study examined premenopausal women with early-stage breast cancer undergoing treatment with OFS and ET. The primary endpoint was the percentage of patients with inadequate ovarian suppression (estradiol ≥10 pg/mL) during OFS cycle 2 or later. The secondary endpoint was the percentage of patients with inadequate ovarian suppression within the first cycle after OFS initiation. Differences in age, body mass index (BMI), and previous chemotherapy use were summarized via multivariable logistic regression.
Of the 131 patients included in the analysis, 35 (26.7%) lacked adequate suppression during OFS cycle 2 or later cycles. Patients with adequate suppression throughout treatment were more likely to be older (odds ratio [OR] 1.12 [95% CI, 1.05-1.22], P = .02), have a lower BMI (OR 0.88 [95% CI, 0.82-0.94], P < .001), and have received chemotherapy (OR 6.30 [95% CI, 2.06-20.8], P = .002). A total of 20 of 83 patients (24.1%) had an inadequately suppressed estradiol level within 35 days of OFS initiation.
This "real world" cohort demonstrates that estradiol concentrations above the postmenopausal range of the assay are frequently detected, including more than 1 year after the start of OFS. Additional research is needed to establish estradiol monitoring guidelines and optimal degree of ovarian suppression.
Details
- Title: Subtitle
- Ovarian Function Suppression in Premenopausal Women With Concurrent Endocrine Therapy Use
- Creators
- Nicole M Grogan FleegeYajing LiKelley M Kidwell - Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MIN Lynn Henry - University of Michigan Medical School
- Resource Type
- Journal article
- Publication Details
- Clinical breast cancer, Vol.23(4), pp.454-460
- DOI
- 10.1016/j.clbc.2023.03.009
- PMID
- 37076363
- ISSN
- 1526-8209
- eISSN
- 1938-0666
- Language
- English
- Electronic publication date
- 03/28/2023
- Date published
- 06/2023
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984398347102771
Metrics
15 Record Views